{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:58:50Z","timestamp":1794808730898,"version":"4.9.1"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T00:00:00Z","timestamp":1337299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["beva.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Equine Veterinary Journal"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Reasons for performing study:<\/jats:bold>\n                    Equine pituitary pars intermedia dysfunction (PPID) is an ageing\u2010related neurodegenerative disorder. The prevalence and risk factors for PPID using seasonally adjusted basal adrenocorticotropic hormone (ACTH) concentrations in aged horses have not been previously reported.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    To determine the prevalence, risk factors and clinical signs predictive for PPID in a population of horses aged \u226515 years in Queensland, Australia.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Owner\u2010reported data was obtained using a postal questionnaire distributed to an equestrian group. A subgroup of surveyed owners were visited and a veterinary physical examination performed on all horses aged \u226515 years. Blood samples were analysed for basal plasma alpha melanocyte\u2010stimulating hormone (\u03b1\u2010MSH) and ACTH concentrations, routine haematology and selected biochemistry. Aged horses with elevations above seasonally adjusted cut\u2010off values for basal plasma ACTH were considered positive for PPID. Positive horses were compared with their aged counterparts to determine risk factors and clinical signs associated with PPID.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Pituitary pars intermedia dysfunction was prevalent in aged horses (21.2%) despite owners infrequently reporting it as a known or diagnosed disease or disorder. Numerous clinical or historical signs were associated with an increased risk of PPID in the univariable model, but only age (odds ratio (OR) 1.18; 95% confidence interval (CI) 1.11\u20131.25, P&lt;0.001) and owner\u2010reported history of hirsutism (OR 7.80; 95% CI 3.67\u201316.57, P&lt;0.001) remained in the final multivariable model. There were no routine haematological or biochemical variables supportive of a diagnosis of PPID.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions and potential relevance:<\/jats:bold>\n                    Pituitary pars intermedia dysfunction occurs commonly in aged horses despite under\u2010recognition by owners. The increased risk of PPID with age supports that this is an ageing associated condition. Aged horses with clinical or historical signs consistent with PPID, especially owner\u2010reported hirsutism (delayed shedding and\/or long hair coat), should be tested and appropriate treatment instituted.\n                  <\/jats:p>","DOI":"10.1111\/j.2042-3306.2012.00578.x","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T02:48:05Z","timestamp":1337309285000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses"],"prefix":"10.1111","volume":"45","author":[{"given":"T. W.","family":"MCGOWAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. P.","family":"PINCHBECK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M.","family":"MCGOWAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,18]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"237","article-title":"Pituitary pars intermedia dysfunction: equine Cushing's disease","volume":"18","author":"Schott H.C.","year":"2002","journal-title":"Vet. Clin. N. Am.: Equine Pract."},{"key":"e_1_2_8_3_2","first-page":"1133","article-title":"Absence of dopaminergic control on melanotrophs leads to Cushing's\u2010like syndrome in mice","volume":"12","author":"Saiardi A.","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"e_1_2_8_4_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arr.2007.02.001","article-title":"Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease","volume":"6","author":"McFarlane D.","year":"2007","journal-title":"Ageing Res. Rev."},{"key":"e_1_2_8_5_2","first-page":"S161","article-title":"3\u2010nitrotyrosine accumulation and increased alpha\u2010synuclein expression in horses with pituitary pars intermedia dysfunction (PPID.)","volume":"37","author":"McFarlane D.","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"e_1_2_8_6_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2826.2005.01277.x","article-title":"Nitration and increased alpha\u2010synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction","volume":"17","author":"McFarlane D.","year":"2005","journal-title":"J. Neuroendocrinol."},{"key":"e_1_2_8_7_2","first-page":"602","article-title":"Cerebrospinal fluid concentration of hypocretin\u20101 in horses with equine pituitary pars intermedia","volume":"21","author":"McFarlane D.","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"e_1_2_8_8_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/030098589902700606","article-title":"Immunocytochemical demonstration of proopiomelanocortin\u2010derived peptides in pituitary adenomas of the pars intermedia in horses","volume":"27","author":"Heinrichs M.","year":"1990","journal-title":"Vet. Pathol."},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2460\/javma.2003.223.93","article-title":"Demographic and clinical characteristics of geriatric horses: 467 cases (1989\u20101999)","volume":"223","author":"Brosnahan M.M.","year":"2003","journal-title":"J. Am. Vet. Med. Ass."},{"key":"e_1_2_8_10_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0007-1935(05)80084-3","article-title":"Equine Cushing's disease","volume":"149","author":"Love S.","year":"1993","journal-title":"Vet. J."},{"key":"e_1_2_8_11_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/inpract.25.10.586","article-title":"Diagnostic and management protocols for equine Cushing's syndrome","volume":"25","author":"McGowan C.","year":"2003","journal-title":"In Pract."},{"key":"e_1_2_8_12_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jevs.2008.04.004","article-title":"Endocrine testing in horses: metabolic syndrome and Cushing's disease","volume":"28","author":"Divers T.J.","year":"2008","journal-title":"J. Equine Vet. Sci."},{"key":"e_1_2_8_13_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1939-1676.1996.tb02016.x","article-title":"Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism","volume":"10","author":"Couetil L.","year":"1996","journal-title":"J. Vet. Intern. Med."},{"key":"e_1_2_8_14_2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide","volume":"34","author":"Perkins G.A.","year":"2002","journal-title":"Equine Vet. J."},{"key":"e_1_2_8_15_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1354\/vp.45-1-26","article-title":"Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction","volume":"45","author":"Miller M.A.","year":"2008","journal-title":"Vet. Pathol."},{"key":"e_1_2_8_16_2","first-page":"987","article-title":"Evaluation of the combined dexamethasone suppression\/thyrotropin\u2010releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses","volume":"20","author":"Frank N.","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"e_1_2_8_17_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.2042-3306.2012.00575.x","article-title":"Evaluation of basal plasma \u03b1\u2010melanocyte\u2010stimulating hormone and adrenocorticotropic hormone concentrations for the diagnosis of PPID from a population of aged horses","volume":"45","author":"McGowan T.W.","year":"2013","journal-title":"Equine Vet. J."},{"key":"e_1_2_8_18_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2460\/javma.2003.223.99","article-title":"Assessment of clinical characteristics, management practices, and activities of geriatric horses","volume":"223","author":"Brosnahan M.M.","year":"2003","journal-title":"J. Am. Vet. Med. Ass."},{"key":"e_1_2_8_19_2","first-page":"217","volume-title":"Proceedings of the Congress of the British Equine Veterinary Association","author":"Chandler K.J.","year":"2001"},{"key":"e_1_2_8_20_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/vr.149.14.417","article-title":"Sentinel practice\u2010based survey of the management and health of horses in northern Britain","volume":"149","author":"Mellor D.J.","year":"2001","journal-title":"Vet. Rec."},{"key":"e_1_2_8_21_2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1751-0813.2010.00637.x","article-title":"A survey of aged horses in Queensland, Australia. Part 1: management and preventive health care","volume":"88","author":"McGowan T.W.","year":"2010","journal-title":"Aust. Vet. J."},{"key":"e_1_2_8_22_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bimj.200710415","article-title":"Youden index and optimal cut\u2010point estimated from observations affected by a lower limit of detection","volume":"50","author":"Ruopp M.D.","year":"2008","journal-title":"Biom. J."},{"key":"e_1_2_8_23_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1751-0813.2010.00638.x","article-title":"A survey of aged horses in Queensland, Australia. Part 2: clinical signs and owner perceptions of health and welfare","volume":"88","author":"McGowan T.W.","year":"2010","journal-title":"Aust. Vet. J."},{"key":"e_1_2_8_24_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.2042-3306.2010.00361.x","article-title":"Disease prevalence in geriatric horses in the United Kingdom: veterinary clinical assessment of 200 cases","volume":"44","author":"Ireland J.L.","year":"2012","journal-title":"Equine Vet. J."},{"key":"e_1_2_8_25_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.prevetmed.2004.01.013","article-title":"Owners' perceptions of the health and performance of Pony Club horses in Australia","volume":"63","author":"Buckley P.","year":"2004","journal-title":"Prev. Vet. Med."},{"key":"e_1_2_8_26_2","first-page":"8","article-title":"The geriatric horse","volume":"17","author":"Hintz H.F.","year":"1995","journal-title":"Equine Pract."},{"key":"e_1_2_8_27_2","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2460\/ajvr.2004.65.1701","article-title":"Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma","volume":"65","author":"van der Kolk J.H.","year":"2004","journal-title":"Am. J. Vet. Res."},{"key":"e_1_2_8_28_2","first-page":"41","article-title":"The equine Cushing's syndrome (ECS): a case report, review of its diagnosis and therapy, and main differences to canine Cushing's syndrome","volume":"26","author":"Fey K.","year":"1998","journal-title":"Tierarztl. Prax. Ausg. G. Grosstiere Nutztiere"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.2042-3292.1992.tb01595.x","article-title":"Diagnosis of hyperadrenocorticism in the horse","volume":"4","author":"Hillyer M.H.","year":"1992","journal-title":"Equine Vet. Educ."},{"key":"e_1_2_8_30_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tvjl.2011.03.021","article-title":"A survey of health care and disease in geriatric horses aged 30 years or older","volume":"192","author":"Ireland J.L.","year":"2012","journal-title":"Vet. J."},{"key":"e_1_2_8_31_2","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2460\/ajvr.1998.59.10.1247","article-title":"Hematologic and serum biochemical variables and plasma corticotropin concentration in healthy aged horses","volume":"59","author":"McFarlane D.","year":"1998","journal-title":"Am. J. Vet. Res."},{"issue":"1","key":"e_1_2_8_32_2","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jcpa.2009.10.007","article-title":"Immunosenescence of the equine immune system","volume":"142","author":"Horohov D.W.","year":"2010","journal-title":"J. Comp. Pathol."},{"key":"e_1_2_8_33_2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2746\/0425164044877288","article-title":"Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitors and prognostic value","volume":"36","author":"McGowan C.M.","year":"2004","journal-title":"Equine Vet. J."},{"key":"e_1_2_8_34_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jevs.2008.08.004","article-title":"Role of insulin in endocrinopathic laminitis","volume":"28","author":"McGowan C.M.","year":"2008","journal-title":"J. Equine Vet. Sci."}],"container-title":["Equine Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-3306.2012.00578.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.2042-3306.2012.00578.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:40:56Z","timestamp":1762072856000},"score":1,"resource":{"primary":{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/10.1111\/j.2042-3306.2012.00578.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.2042-3306.2012.00578.x"],"URL":"https:\/\/doi.org\/10.1111\/j.2042-3306.2012.00578.x","archive":["Portico"],"relation":{},"ISSN":["0425-1644","2042-3306"],"issn-type":[{"value":"0425-1644","type":"print"},{"value":"2042-3306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,18]]},"assertion":[{"value":"2012-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}